21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.99.Z - Retail trade
49.41.Z - Road freight transport
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,6 | -2,5 | 0,5 | 120,9 |
EBITDA | 2,1 | 1,2 | 5,1 | 326,6 |
Short time liabilities | 1,3 | 1,6 | 3,4 | 110,6 |
Equity capital | -19,1 | -21,6 | -21,1 | 2,4 |
Operating profit (EBIT) | 0,4 | -0,6 | 3 | 575,4 |
Assets | 24,2 | 24,1 | 28,3 | 17,5 |
Net profit (loss) | -1,6 | -2,5 | 0,5 | 120,9 |
Cash | 1,1 | 1,4 | 0,3 | -79,5 |
Net income from sale | 8,4 | 9,3 | 14,7 | 58,4 |
Liabilities and provisions for liabilities | 43,3 | 45,7 | 49,4 | 8,1 |
Working assets | 6,1 | 6,4 | 10,9 | 69,6 |
Depreciation | 1,7 | 1,8 | 2,1 | 13,6 |
% | % | % | p.p. | |
Profitability of capital | 8,2 | 11,4 | -2,4 | -13,8 |
Equity capital to total assets | -78,7 | -89,7 | -74,5 | 15,2 |
Gross profit margin | -18,5 | -26,6 | 3,5 | 30,1 |
EBITDA Margin | 24,9 | 13 | 34,9 | 21,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 57 | 63 | 84 | 21 |
Current financial liquidity indicator | 1.6151396036148071 | 1.5389502048492432 | 1.8300217390060425 | 0,3 |
Net dept to EBITDA | 18.306049346923828 | 33.39771270751953 | 8.410961151123047 | -25 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane